Forward Citations = 41

Loading Chart...

5 inventors (with patents filed for the assignee):

Vyacheslav G Morozov (3 out of 14 patents)

Vladimir K Khavinson (2 out of 2 patents)

Vyacheslav G Morozov (2 out of 2 patents)

4. Vladimir Kh Khavinson (2 out of 6 patents)

5. Vladimir Khatskelevich Khavinson (1 out of 18 patents)

5 patents: Sort by Forward Citations

1. 5814611 - Pharmaceutical for the therapy of immune deficiency conditions (1998-09-29),

2. 5807830 - Method for treatment of purulent inflammatory diseases (1998-09-15),

3. 5767087 - Pharmaceutical preparation for the therapy of immune deficiency (1998-06-16),

4. 5728680 - Methods for normalizing numbers of lymphocytes (1998-03-17),

5. 5538951 - Pharmaceutical preparation for the therapy of immune deficiency (1996-07-23),

Company Overview

Cytoven J.v. is a biotechnology company specializing in the development of innovative cell therapies for the treatment of cancer. Our mission is to revolutionize the way cancer is treated by harnessing the power of the immune system to target and destroy cancer cells. With a team of experienced researchers and scientists, we are dedicated to advancing cutting-edge technologies and bringing life-saving treatments to patients in need.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

5 Patents

#47 in Kirkland, WA

#1,240 in Washington

#51,644 in US

Kirkland, WA, United States of America

Cytoven J.v.

Forward Citations = 41

5 inventors:

Vyacheslav G Morozov (3 out of 14 patents)

Vladimir K Khavinson (2 out of 2 patents)

Vyacheslav G Morozov (2 out of 2 patents)

4. Vladimir Kh Khavinson (2 out of 6 patents)

5. Vladimir Khatskelevich Khavinson (1 out of 18 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cytoven J.v.. Retrieved from https://idiyas.com/company/cytoven-j-v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]